• Skip to main content
  • Skip to footer

Oklahoma Medical Research Foundation | OMRF

OMRF is an independent, nonprofit biomedical research institute dedicated to discoveries that make a difference.

  • About
    • General Information
    • Disease Research
    • Education & Outreach
    • Events
    • Jobs
    • Contact Us
  • Science
    • Scientist Directory
    • Research Programs
    • Research Centers
    • Core Facilities
    • Scientific Publications
    • Scientific Seminars
    • Technology Ventures
  • News
    • Media Resources
    • OMRF in the Media
    • OMRF News
    • OMRF Publications
    • OMRF Videos
    • Dr. Prescott’s Columns
  • Patients
    • Lupus (SLE)
    • MBTPS1 Related Disorders
    • Multiple Sclerosis
    • Rheumatoid Arthritis
    • Sarcoidosis
    • Sjögren’s Syndrome
    • Other Autoimmune Disorders
  • Donate
    • Donate Now
    • Tax Credit
    • Planned Giving
    • Vehicle Donations
    • Why We Give
    • Your Gift at Work
    • Donor Recognition
    • Contact
Home - OMRF News - Archives for develop

develop

Genes, Epstein-Barr virus may trigger lupus in some

August 26, 2019

Scientists have long known lupus has a strong genetic component, but there also must be environmental triggers to activate the disease.

Filed Under: News Tagged With: antibodies, autoimmune, autoimmunity, clinic, develop, ebv, environmental, epstein-barr, genes, human, James, Judith, lupus, neelakshi jog, news, newsok, NIAMS, NIH, OKC, Oklahoma City, Oklahoma Medical Research Foundation, OMRF, research, science, scientist-news, trigger, virus

OMRF receives $1.47 million grant to study cell division

February 25, 2019

OMRF scientist Susannah Rankin received a four-year, $1.47 million award to study chromosomes.

Filed Under: News Tagged With: biology, cancer, cell division, cells, chromosomes, develop, grant, National Institute of General Medical Sciences, National Institutes of Health, news, newsok, NIH, OKC, Oklahoma City, Oklahoma Medical Research Foundation, OMRF, Rankin, research, science, scientist-news, Susannah, Susannah Rankin, treatment

New findings cast light on lymphatic system, key player in human health

October 16, 2018

OMRF researchers have broken new ground in understanding how the lymphatic system works.

Filed Under: News Tagged With: alzheimers, atherosclerosis, cancer, cell, cell reports, cells, develop, development, disorders, drug targets, drugs, health, infections, Lorin, lymph, lymphatic, lymphedema, news, newsok, obesity, OKC, Oklahoma, Oklahoma City, Oklahoma Medical Research Foundation, Olson, OMRF, pathway, Sathish, Sathish Srinivasan, scientist-news, Srinivasan, st. jude's, system, therapies, therapy

Staying alive: Can an experimental OMRF drug stop Mike Schuster’s brain cancer?

September 11, 2018

As Mike Schuster nears the three-year anniversary of his diagnosis with glioblastoma, he’s already doubled the life expectancy for patients with the deadly cancer.

Filed Under: News, Technology Ventures News Tagged With: aggressive, battiste, brain, brain cancer, cancer, deadly, death, develop, disease, drug, glioblastoma, john mccain, life expectancy, live, longer, mike schuster, MRI, newsok, Norman, OKC, Oklahoma City, Oklahoma Medical Research Foundation, OKN-007, OMRF, OUHSC, patients, Rheal, scientist-news, Stephenson Cancer Center, Towner, tumor

OMRF receives $2.8 million grant to study rare disorder

August 23, 2018

The grant will provide Bob Axtell with $2.8 million to study NMO and investigate its similarities to other autoimmune diseases, particularly MS.

Filed Under: News Tagged With: allergy, approved, autoimmune, Axtell, Bob Axtell, brain stem, consequences, develop, disease, infectious diseases, interferon, interferon beta, lupus, multiple sclerosis, National Institutes of Health, neuromyelitis optica, new, news, newsok, NIAID, NIH, NMO, OKC, Oklahoma Medical Research Foundation, OMRF, option, robert, Robert Axtell, scientist-news, therapy, treatment

Experts propose improving clinical trials for lupus

April 23, 2018

The goal of the new white paper is to create a dramatic shift in how lupus clinical trials are conducted so effective treatments can stand a chance to succeed.

Filed Under: News Tagged With: autoimmune disease, barriers, clinical, clinical trials, design, develop, drugs, effort, FDA, illness, immonology, James, Joan, Joan Merrill, Judith, Judith James, lfa, lupus, Lupus Foundation of America, medicine, Merrill, new, Oklahoma Medical Research Foundation, OMRF, projects, research, scientist-news, specialists, therapies, treatment, us, white paper

  • Go to page 1
  • Go to page 2
  • Go to Next Page »

Before Footer

EEO/AA Employer/Vet/Disabled

Footer

  • Jobs
  • Directory
  • Donor Privacy Statement
  • Intranet
Charity navigator
United Way Give Smart OKC
Facebook Twitter YouTube Instagram Mail Linkedin
Administrator Log In